The vitamin D prodrugs 1α(OH)D2 1α(OH)3 and BCI-210 suppress PTH secretion by bovine parathyroid cells

Nephrology Dialysis Transplantation

Volumn 21, Issue 3, 2006, Pages 644-650

  Brown, Alex J ^a   Ritter, Cynthia S ^a   Knutson, Joyce C ^b   Strugnell, Stephen A ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Preclinical Research   (United States)

Author keywords

hydroxyvitamin D2; 1 ; 1 hydroxyvitamin D3; BCI 210; Ketoconazole; Parathyroid hormone; Vitamin D

Indexed keywords

1ALPHA HYDROXY 24 METHYL 25 ENE VITAMIN D2; ALFACALCIDOL; BCI 210; DOXERCALCIFEROL; KETOCONAZOLE; PARATHYROID HORMONE; PRODRUG; TRITIUM; UNCLASSIFIED DRUG; VITAMIN D DERIVATIVE; VITAMIN D RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; COW; DRUG STRUCTURE; HORMONE RELEASE; HORMONE SYNTHESIS; HYPERPARATHYROIDISM; IN VITRO STUDY; NONHUMAN; PARATHYROID CELL; PARATHYROID GLAND; PRIORITY JOURNAL; VITAMIN D METABOLISM;

ANIMALS; BONE DENSITY CONSERVATION AGENTS; CATTLE; CELLS, CULTURED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOCHROME P-450 ENZYME SYSTEM; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERGOCALCIFEROLS; GENE EXPRESSION; HYDROXYCHOLECALCIFEROLS; KETOCONAZOLE; PARATHYROID GLANDS; PARATHYROID HORMONE; RNA, MESSENGER; VITAMIN D;

EID: 33644863882     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfi186     Document Type: Article

References (26)

1. Brown AJ, Dusso AS, Slatopolsky E. Vitamin D analogs for secondary hyperparathyroidism. Nephrol Dial Transpl 2002; 17 [Suppl 10]: 10-19
2. Drueke TB. Treatment of secondary hyperparathyroidism with vitamin D derivatives and calcimimetics before and after start of dialysis. Nephrol Dial Transplant 2002;17 [Suppl 11]:20-22
3. Silver J, Naveh-Many T, Mayer H, Schmelzer HJ, Popovtzer MM. Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat. J Clin Invest 1986; 78: 1296-1301
4. 3 and high calcium on transcription of the pre-proparathyroid hormone gene are direct. Transact Assoc Am Physician 1987; 100: 256-262
5. 3 inhibits parathyroid cell proliferation in experimental uremia. Kidney Int 1989; 35: 1049-1056
6. Henry HL, Norman AW. Studies on the mechanism of action of calciferol VII. Localization of 1,25-dihydroxy-vitamin D3 in chick parathyroid glands. Biochem Biophys Res Commun 1975; 62: 781-788
7. Stumpf WE, Sar M, Reid FA, Tanaka Y, DeLuca HF. Target cells for 1,25-dihydroxyvitamin D3 in intesinal tract, stomach, kidney, skin, pituitary and parathyroid. Science 1979; 206: 1188-1190
8. Brumbaugh PF, Hughes MR, Haussler MR. Cytoplasmic and nuclear binding components for 1alpha25-dihydroxyvitamin D3 in chick parathyroid glands. Proc Natl Acad Sci USA 1975; 72: 4871-4875
9. Bouillon R, Okamura WH, Norman AW. Structure-function relationships in the vitamin D endocrine system. Endocr Rev 1995; 16: 200-257
10. Nielsen PK, Feldt-Rasmussen U, Olgaard K. J Am Soc Nephrol 1997; 8: 578A, abst no 2691
11. Lee NE, Reddy GS, Brown AJ, Williard PG. Synthesis, stereochemistry, and biological activity of 1alpha,23, 25-trihydroxy-24-oxovitamin D3, a major natural metabolite of 1alpha, 25-dihydroxyvitamin D3. Biochemistry 1997; 36: 9429-9437
12. 3, is a potent suppressor of parathyroid hormone secretion. J Cell Biochem 1999; 73: 106-113
13. 3-24-hydroxylase in parathyroid tumors-New prospects for treatment of hyperparathyroidism with vitamin D. J Clin Endocrinol Metab 2002; 87: 5826-5829
14. 2 made in the human hepatoma, Hep3B. Biochem J 1995; 310: 233-241
15. 3 in cultured bovine parathyroid cells. Endocrinology 1992; 130: 276-281
16. Ritter CS, Santoro S, Slatopolsky E, Brown AJ. Parathyroid cells cultured in collagen matrix retain calcium responsiveness: Importance of three-dimensional tissue architecture. J Bone Min Res 2004; 19: 491-498
17. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959; 37: 911-917
18. 2, suppresses parathyroid hormone secretion in uremic rats in the absence of hypercalcemia. Am J Kidney Dis 1995; 26: 852-860
19. 3 regarding suppression of parathyroid hormone and calcemic action. Nephrol Dial Transplant 2002; 17 [Suppl 10]: 41-45
20. 3 in normal and uraemic men. Nephrol Dial Transplant 2002; 17: 829-842
21. Guo YD, Strugnell S, Back DW, Jones G. Transfected human liver cytochrome P-450 hydroxylates vitamin D analogs at different side-chain positions. Proc Natl Acad Sci USA 1993; 90: 8668-8672
22. Jones G, Strugnell SA, DeLuca HF. Current understanding of the molecular actions of vitamin D. Physiol Rev 1998; 78: 1193-1231
23. 2) in dialysis patients with secondary hyperparathyroidism: A sequential comparison. Am J Kidney Dis 2001; 37: 532-543
24. Panda DK, Miao D, Bolivar I et al. Inactivation of the 25-hydroxyvitamin D 1alpha-hydroxylase and vitamin D receptor demonstrates independent and interdependent effects of calcium and vitamin D on skeletal and mineral homeostasis. J Biol Chem 2004; 279: 16754-16766
25. Plum LA, Prahl JM, Ma X et al. Biologically active noncalcemic analogs of 1α,25-dihydroxyvitamin D with an abbreviated side chain containing no hydroxyl. Proc Natl Acad Sci USA 2004; 101: 6900-6904
26. Slatopolsky E, Finch J, Plum LA, Clagett-Dame M, Sicinski RF, DeLuca HF. A new vitamin D analog without calcemic and phosphatemic effects. J Am Soc Nephrol 2003; 14: 48A